<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36">
 <label>36.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pavot</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Rochereau</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Rességuier</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Gutjahr</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Genin</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Tiraby</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Cutting edge: new chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity</article-title>. 
  <source>J Immunol.</source> (
  <year>2014</year>) 
  <volume>193</volume>:
  <fpage>5781</fpage>–
  <lpage>5</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.1402184</pub-id>
  <?supplied-pmid 25392526?>
  <pub-id pub-id-type="pmid">25392526</pub-id>
 </mixed-citation>
</ref>
